361 related articles for article (PubMed ID: 38828195)
1. Brain Targeting Nanomedicines: Pitfalls and Promise.
Kakinen A; Jiang Y; Davis TP; Teesalu T; Saarma M
Int J Nanomedicine; 2024; 19():4857-4875. PubMed ID: 38828195
[TBL] [Abstract][Full Text] [Related]
2. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
5. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
6. The Therapeutic Benefits of Intravenously Administrated Nanoparticles in Stroke and Age-related Neurodegenerative Diseases.
Farhoudi M; Sadigh-Eteghad S; Mahmoudi J; Farjami A; Mahmoudian M; Salatin S
Curr Pharm Des; 2022; 28(24):1985-2000. PubMed ID: 35676838
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
9. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine against Alzheimer's and Parkinson's Disease.
Tandon A; Singh SJ; Chaturvedi RK
Curr Pharm Des; 2021; 27(12):1507-1545. PubMed ID: 33087025
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
12. Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems.
Roghani AK; Garcia RI; Roghani A; Reddy A; Khemka S; Reddy RP; Pattoor V; Jacob M; Reddy PH; Sehar U
Ageing Res Rev; 2024 Jun; 97():102291. PubMed ID: 38614367
[TBL] [Abstract][Full Text] [Related]
13. Development of nanomedicines for the treatment of Alzheimer's disease: Raison d'être, strategies, challenges and regulatory aspects.
Mazahir F; Alam MI; Yadav AK
Ageing Res Rev; 2024 Jul; 98():102318. PubMed ID: 38705362
[TBL] [Abstract][Full Text] [Related]
14. Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases.
Pirhaghi M; Mamashli F; Moosavi-Movahedi F; Arghavani P; Amiri A; Davaeil B; Mohammad-Zaheri M; Mousavi-Jarrahi Z; Sharma D; Langel Ü; Otzen DE; Saboury AA
Mol Pharm; 2024 May; 21(5):2097-2117. PubMed ID: 38440998
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.
Kulkarni AD; Vanjari YH; Sancheti KH; Belgamwar VS; Surana SJ; Pardeshi CV
J Drug Target; 2015; 23(9):775-88. PubMed ID: 25758751
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.
Cunha S; Amaral MH; Lobo JM; Silva AC
Curr Med Chem; 2016; 23(31):3618-3631. PubMed ID: 27554805
[TBL] [Abstract][Full Text] [Related]
18. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
19. Micro- and nanotechnology approaches to improve Parkinson's disease therapy.
Torres-Ortega PV; Saludas L; Hanafy AS; Garbayo E; Blanco-Prieto MJ
J Control Release; 2019 Feb; 295():201-213. PubMed ID: 30579984
[TBL] [Abstract][Full Text] [Related]
20. Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders.
Yadav K; Vijayalakshmi R; Kumar Sahu K; Sure P; Chahal K; Yadav R; Sucheta ; Dubey A; Jha M; Pradhan M
Eur J Pharm Biopharm; 2024 Jun; 199():114298. PubMed ID: 38642716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]